HealthRX.com · Printable supplement log
EGRIFTA and magnesium supplement log with glucose and magnesium results
Record which EGRIFTA product you use, exactly what magnesium product and amount you take, any medicines that lower magnesium, and each glucose or magnesium result with its date. Share it with your prescriber, who can read your glucose results correctly only if they know about the supplement.
Your EGRIFTA
ProductEGRIFTA WR or EGRIFTA SV
Date started
Prescriber
Glucose result before starting, and its datefasting glucose or HbA1c
Your magnesium product
Product name and formglycinate, citrate, oxide or other
Elemental magnesium per serving, as printed on the label
Servings you take each day
Why you started it, and who suggested it
Medicines that lower magnesium or call for magnesium checks: tick any you take
- A proton pump inhibitor, such as omeprazole or pantoprazole
- A diuretic (water pill)
- Digoxin (the omeprazole label names it among reasons to check magnesium)
- Tenofovir disoproxil fumarate
Results over time
| Date | Fasting glucose or HbA1c | Magnesium level, if tested | Stomach upset or diarrhea | Notes |
|---|---|---|---|---|
From the labels and the trials
- EGRIFTA WR and SV labels (section 5.4): treatment can cause glucose intolerance; glucose should be evaluated before starting and monitored periodically.[1]
- In the EGRIFTA trials, HbA1c reached 6.5% or more by week 26 in 5% of patients on EGRIFTA versus 1% on placebo.[1]
- Section 5.1 of both labels (Increased Risk of Neoplasms): weigh the higher background cancer risk in people with HIV before starting, do not use EGRIFTA with an active malignancy, and stop it if a cancer recurs.[2]
- The labels' interaction section (7.1 and 7.2) covers CYP450-metabolized drugs and glucocorticoids; magnesium is not mentioned.[1]
- The omeprazole (Prilosec) label: low magnesium has been reported rarely with proton pump inhibitors after at least three months of use, mostly after a year; checking magnesium may be considered for long-term use or alongside digoxin or diuretics.[3]
- In pooled trials in people with diabetes, oral magnesium lowered fasting glucose modestly versus placebo (standardized mean difference -0.40).[4]
For your prescriber
- Should my magnesium level be checked before I add a supplement?
- Do any of my HIV or stomach medicines lower magnesium?
- How often should my glucose or HbA1c be checked while I am on EGRIFTA?
- Does my kidney function limit magnesium supplements?
Sources for the facts on this sheet
- Theratechnologies Inc., via DailyMed. EGRIFTA WR (tesamorelin) for injection, for subcutaneous use: prescribing information, patient information and instructions for use. Effective 2026-07-29. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=839334d3-8c1d-4c26-9036-2ab524a6ea75
- Theratechnologies Inc., via DailyMed. EGRIFTA SV (tesamorelin) for injection, for subcutaneous use: prescribing information, patient information and instructions for use. Effective 2026-07-29. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d783378-b02d-4f19-99dd-0fc91a042224
- Covis Pharma US, Inc., via DailyMed. PRILOSEC (omeprazole magnesium) for delayed-release oral suspension: prescribing information. Effective 2024-03-19. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6761f84-53ac-4745-a8c8-1e5427d7e179
- Veronese N, Watutantrige-Fernando S, Luchini C, et al. Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials. Eur J Clin Nutr 2016. PMID 27530471. https://pubmed.ncbi.nlm.nih.gov/27530471/
This sheet records information for a conversation with your prescriber or pharmacist. It does not replace their instructions or the medication's prescribing information.